Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

On Saturday, the Juice hitmaker took to Instagram to share a video of herself modeling a sexy piece of swimwear from her ...

Around 1.5 million people in the UK are thought to be using weight loss jabs, with many paying privately as NHS supplies ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Weight-loss supplements recommended by influencers on social mead are generally ineffective for weight loss, but do have some benefits.

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

Lizzo has shown off her dramatic weight loss in a new Instagram before-and-after post - and fans are all saying the same ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.